We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tyratech (DI/S) | LSE:TYR | London | Ordinary Share | COM SHS USD0.001 (DI / REGS) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.95 | 2.70 | 3.20 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMTYR TIDMTYRU
RNS Number : 2020C
TyraTech, Inc.
15 January 2015
15 January 2015
TyraTech, Inc.
("TyraTech" or the "Company")
Appointment of Chief Financial Officer and Treasurer
TyraTech, Inc. (AIM: TYR and TYRU), a life sciences company focusing on nature-derived insect and parasite control products, announces the appointment of Vincent T. "Vince" Morgus MBA, CPA, as Chief Financial Officer and Treasurer effective immediately.
Mr Morgus takes over from Daniel Williams who is retiring following a long and successful career.
Mr Morgus, an American national, earned a BS in Accounting from Pennsylvania State University and an MBA from the University of North Carolina at Chapel Hill. He held positions at firms including Ernst & Young and Arthur Andersen before joining Quintiles, USA in 1994, the world's largest provider of biopharmaceutical development and outsourcing services. Mr Morgus spent 16 plus years in senior positions at Quintiles, including Director, Finance, Treasurer, VP, Business Operations Planning and Analysis, Interim Chief Financial Officer (Quintiles, Tokyo), and finally as Senior Vice President, Corporate Development.
More recently, Mr Morgus held the position of Chief Financial Officer with Cornerstone Therapeutics, Inc. a publicly traded speciality pharmaceutical company with approximately 100 employees.
Prior to joining Tyratech, Mr Morgus was Chief Financial Officer with Lulu Press, Inc. a private self-publishing ecommerce company with approximately 80 employees.
Bruno Jactel, CEO of TyraTech, said: "We are delighted that Vince has joined TyraTech as Chief Financial Officer. He is a proven finance leader and corporate developer and his considerable experience will be invaluable to the Company as we continue to expand into the retail markets of the USA and Europe. I would also like to thank Daniel Williams for his substantial contribution to the Company since 2007 and wish him all the best for the future."
For further information please contact:
TyraTech Inc. Tel: +1 919 415 4340 Bruno Jactel, Chief Executive Officer Tel: +1-919-415-4287 Vincent Morgus, Chief Financial Officer Tel: +44 78 4197 8709 Alan Reade, Non-Executive Chairman SPARK Advisory Partners Limited, Nominated Tel: +44 20 3368 3551 Adviser Matt Davis / Mark Brady Allenby Capital Limited, Joint Broker Tel: +44 20 3328 5656 Chris Crawford Whitman Howard, Joint Broker Tel: 44 20 7087 4550 Ranald McGregor-Smith/ Niall Devins Walbrook, Financial PR and IR Tel: +44 20 7933 8792 Bob Huxford /Guy McDougall
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCLLFEDLAISLIE
1 Year Tyratech Chart |
1 Month Tyratech Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions